Quote | Agentix Corp - Ordinary Shares (OTCMKTS:AGTX)
Last: | $0.0322 |
---|---|
Change Percent: | -27.33% |
Open: | $0.041 |
Close: | $0.0322 |
High: | $0.041 |
Low: | $0.0322 |
Volume: | 1,256 |
Last Trade Date Time: | 03/21/2024 03:00:00 am |
News | Agentix Corp - Ordinary Shares (OTCMKTS:AGTX)
Phoenix, Arizona--(Newsfile Corp. - January 4, 2022) - The Stock Day Podcast welcomed AGENTIX (OTC Pink: AGTX) ("the Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mel...
New York, New York--(Newsfile Corp. - December 21, 2021) - AGENTIX Corporation (OTC Pink: AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Paten...
Message Board Posts | Agentix Corp - Ordinary Shares (OTCMKTS:AGTX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Agentix Corp - Ordinary Shares Company Name:
AGTX Stock Symbol:
OTCMKTS Market:
Phoenix, Arizona--(Newsfile Corp. - January 4, 2022) - The Stock Day Podcast welcomed AGENTIX (OTC Pink: AGTX) ("the Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mel...
New York, New York--(Newsfile Corp. - December 21, 2021) - AGENTIX Corporation (OTC Pink: AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Paten...
New York, New York--(Newsfile Corp. - September 8, 2021) - AGENTIX Corp. (OTC Pink: AGTX), a pharmaceutical company focused on developing innovative therapeutic treatments targeting the endocannabinoid system (ECS) for the treatment of metabolic diseases, announced today it had entered into a ...